Therapeutic compositions for intranasal administration which include KETOROLAC®

  • US 6,333,044 B1
  • Filed: 02/01/1995
  • Issued: 12/25/2001
  • Est. Priority Date: 07/22/1991
  • Status: Expired due to Term
First Claim
Patent Images

1. An analgesic/anti-inflammatory pharmaceutical liquid dosage form which comprises a systemically effective amount of an active ingredient selected from the group consisting of racemic 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, of the formula optically active forms thereof and pharmaceutically acceptable salts thereof, in combination with a pharmaceutically acceptable excipient or diluent, said dosage form being a non-thermosetting intranasally administrable transmucosally rapidly absorbable dosage form that achieves blood levels in a host effective for analgesic or anti-inflammatory use after intranasal administration.

View all claims

    Thank you for your feedback